tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Coherus Biosciences Regains Nasdaq Compliance
Company AnnouncementsCoherus Biosciences Regains Nasdaq Compliance
24d ago
8K
CHRS
Coherus Biosciences upgraded to Buy from Neutral at Roth Capital
PremiumThe Fly
Coherus Biosciences upgraded to Buy from Neutral at Roth Capital
29d ago
CHRS
Coherus Biosciences upgraded to Buy from Hold at Maxim
PremiumThe Fly
Coherus Biosciences upgraded to Buy from Hold at Maxim
29d ago
CHRS
Coherus Oncology’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Coherus Oncology’s Earnings Call Highlights Growth and Challenges
2M ago
CHRS
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
PremiumRatings
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
2M ago
CHRS
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
PremiumRatingsCoherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
2M ago
CHRS
Coherus Oncology Reports Strong Q2 2025 Growth
Premium
Company Announcements
Coherus Oncology Reports Strong Q2 2025 Growth
2M ago
CHRS
Coherus Biosciences reports Q2 EPS (39c), consensus (27c)
Premium
The Fly
Coherus Biosciences reports Q2 EPS (39c), consensus (27c)
2M ago
CHRS
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CHRS
Coherus Biosciences Receives Nasdaq Deficiency Notice
PremiumCompany Announcements
Coherus Biosciences Receives Nasdaq Deficiency Notice
3M ago
8K
CHRS
Coherus Biosciences Holds Virtual Annual Stockholder Meeting
PremiumCompany Announcements
Coherus Biosciences Holds Virtual Annual Stockholder Meeting
4M ago
8K
CHRS
Coherus Biosciences Rebrands to Coherus Oncology
PremiumCompany Announcements
Coherus Biosciences Rebrands to Coherus Oncology
4M ago
8K
CHRS
Coherus Biosciences completes transformation to Coherus Oncology
PremiumThe FlyCoherus Biosciences completes transformation to Coherus Oncology
4M ago
CHRS
Coherus Biosciences announces clinical collaboration with STORM Therapeutics
Premium
The Fly
Coherus Biosciences announces clinical collaboration with STORM Therapeutics
4M ago
CHRS
Coherus BioSciences Earnings Call Highlights Transition and Growth
Premium
Company Announcements
Coherus BioSciences Earnings Call Highlights Transition and Growth
5M ago
CHRS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
BMY
ABBV
Strategic Divestment and Ambitious Targets Support Coherus Biosciences’ Buy Rating
PremiumRatings
Strategic Divestment and Ambitious Targets Support Coherus Biosciences’ Buy Rating
5M ago
CHRS
Positive Outlook for Coherus Biosciences: Buy Rating Backed by Strong Growth and Strategic Milestones
PremiumRatings
Positive Outlook for Coherus Biosciences: Buy Rating Backed by Strong Growth and Strategic Milestones
5M ago
CHRS
Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
PremiumCompany Announcements
Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
5M ago
CHRS
CHRS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCHRS Upcoming Earnings Report: What to Expect?
5M ago
CHRS
Promising Clinical Data and Strategic Expansion Justify Buy Rating for Coherus Biosciences
Premium
Ratings
Promising Clinical Data and Strategic Expansion Justify Buy Rating for Coherus Biosciences
5M ago
CHRS
Coherus Biosciences presents data from Phase 1 dose expansion study of CHS-114
Premium
The Fly
Coherus Biosciences presents data from Phase 1 dose expansion study of CHS-114
5M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >